Blood Collection Market Size & Growth Forecast 2027–2036, By Segments (Method, Application, End-use, Product Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Blood Collection Market size was worth USD 11.06 Billion in 2026 and is expected to grow at 6.57% CAGR between 2027 and 2036, crossing USD 20.9 Billion by 2036. The industry revenue for 2027 is estimated at USD 11.68 Billion.
Get more details on this report
Request Free Sample ReportBlood Collection Market Intelligence Snapshot
Regional Market Dynamics
- North America held 38.23% in 2026, supported by established healthcare infrastructure, high diagnostic testing utilization, extensive laboratories, and demand for standardized collection solutions.
- Asia Pacific is the fastest-growing region, driven by healthcare infrastructure expansion, greater diagnostic access, rising disease-related testing, and investments in laboratory capabilities.
Segment Momentum
- Manual blood collection accounted for 56.29% of the market in 2026 due to its widespread use, established clinical protocols, accessibility, and suitability for routine diagnostic procedures across healthcare settings.
- Diagnostic centers are the fastest-growing end-use segment as demand rises for specialized testing, faster turnaround times, preventive screening, and decentralized diagnostic services.
Market Expansion Drivers
- Rising prevalence of chronic and infectious diseases increasing global blood testing volumes
- Growing number of surgical procedures driving demand for efficient blood collection systems
- Increasing adoption of automated blood collection devices improving diagnostic workflow efficiency
Leading Market Participants
- Key players in the blood collection market include Becton, Dickinson and Company (United States), Abbott Laboratories (United States), F. Hoffmann-La Roche AG (Switzerland), Terumo Corporation (Japan), Thermo Fisher Scientific Inc. (United States), Siemens Healthineers AG (Germany), Haemonetics Corporation (United States), Greiner AG (Austria), Nipro Corporation (Japan), Sarstedt AG & Co. KG (Germany)
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 11.06 Billion
- 2027 Estimated Market Size: USD 11.68 Billion
- Projected Market Size: USD 20.9 Billion by 2036
- Growth Forecast: 6.57% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Manual Blood Collection (Method) | Diagnostics (Application) | Hospitals and Clinics (End-use) | Venous (Product Type)
- Emerging Opportunity Segment: Automated Blood Collection (Method) | Diagnostics (Application) | Diagnostic Centers (End-use) | Capillary (Product Type)
Market Growth Drivers and Industry Trends
Rising prevalence of chronic and infectious diseases increasing global blood testing volumes
The increasing burden of chronic and infectious diseases is driving greater reliance on laboratory diagnostics for disease detection, monitoring, and treatment planning. The blood collection market growth is driven by expanding blood testing requirements across hospitals, diagnostic laboratories, and outpatient healthcare settings. Healthcare providers are performing more routine and specialized blood analyses to support timely clinical decision-making, increasing demand for reliable blood collection products and procedures.
Growing number of surgical procedures driving demand for efficient blood collection systems
The rising volume of surgical interventions is increasing the need for accurate preoperative, intraoperative, and postoperative laboratory assessments. The blood collection market will benefit from growing demand for efficient collection systems that facilitate safe sample acquisition and support rapid diagnostic testing throughout the patient care pathway. Medical facilities are prioritizing collection solutions that improve sample integrity, streamline clinical workflows, and reduce the risk of handling errors.
Increasing adoption of automated blood collection devices improving diagnostic workflow efficiency
Healthcare institutions are increasingly incorporating automated technologies to enhance laboratory productivity and improve patient experience during sample collection. The blood collection market growth is supported by wider adoption of automated blood collection devices that promote consistent sample quality, reduce manual variability, and optimize diagnostic workflows. These systems assist healthcare professionals by improving operational efficiency while supporting standardized collection practices across diverse clinical environments.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of chronic and infectious diseases increasing global blood testing volumes | 2% | High | North America, Asia Pacific | High | Near Term |
| Growing number of surgical procedures driving demand for efficient blood collection systems | 1.8% | High | Europe, North America | High | Near Term |
| Increasing adoption of automated blood collection devices improving diagnostic workflow efficiency | 1.5% | Moderate | Asia Pacific, Europe | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held the largest share of the blood collection market at 38.23% in 2026, supported by well-established healthcare infrastructure, high utilization of diagnostic testing, and strong demand for reliable blood collection products across hospitals, laboratories, and outpatient care settings. The region's extensive network of clinical laboratories and healthcare facilities supports consistent demand for collection tubes, needles, blood bags, and related consumables. Growing emphasis on early disease detection, routine health screening, and laboratory-based diagnosis is further strengthening blood sample collection volumes. In addition, established quality standards and continued investments in healthcare technology encourage the adoption of efficient and standardized collection solutions.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is anticipated to be the fastest-growing regional market, driven by expanding healthcare infrastructure, increasing access to diagnostic services, and rising awareness of preventive healthcare. The growing patient population and increasing prevalence of chronic and infectious diseases are encouraging greater use of laboratory testing, which in turn is creating sustained demand for blood collection products. Healthcare modernization across emerging economies is also improving the availability of hospitals, diagnostic laboratories, and specialized testing facilities. Government efforts to broaden healthcare access, together with rising investments in clinical infrastructure and laboratory capabilities, are expected to accelerate adoption across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
United States 🇺🇸
Diagnostic Workflow ExpansionThe U.S. blood collection market emphasizes integrated specimen management across hospitals, diagnostic laboratories, and outpatient settings. Manufacturers continue enhancing collection devices with safety-engineered features and workflow efficiency to support growing demand for routine and specialized diagnostic testing.
Germany 🇩🇪
Laboratory Quality StandardsGermany prioritizes blood collection products that align with stringent laboratory quality protocols and clinical safety requirements. Healthcare providers in Germany increasingly adopt standardized collection systems that improve sample integrity and operational consistency across diagnostic facilities.
Japan 🇯🇵
Precision Sampling SolutionsJapan focuses on blood collection technologies that enhance sampling accuracy while improving patient comfort during routine diagnostics. Companies in Japan continue refining collection devices and automation compatibility to support efficient laboratory processing and healthcare delivery.
South Korea 🇰🇷
Hospital Automation SupportSouth Korea advances the blood collection market through modernization of hospital laboratories and expanding diagnostic infrastructure. Manufacturers in South Korea emphasize collection systems that integrate with automated laboratory workflows while supporting reliable specimen handling practices.
France 🇫🇷
Clinical Safety PrioritiesFrance maintains strong demand for blood collection products designed to improve patient safety and reduce occupational exposure risks. Healthcare institutions in France increasingly adopt advanced collection devices that support standardized clinical procedures and dependable diagnostic outcomes.
Italy 🇮🇹
Healthcare Network EfficiencyItaly supports the blood collection market through ongoing improvements in hospital diagnostics and laboratory service coordination. Suppliers in Italy focus on dependable collection systems that facilitate consistent sample quality and efficient clinical workflows across healthcare facilities.
Segment Leadership and Growth Trends
Blood Collection Market Share (%), by Method, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportMethod Segment Analysis: Manual Blood Collection (Largest Segment) vs Automated Blood Collection (Fastest-Growing Segment)
The blood collection market was led by the manual blood collection segment, which accounted for a 56.29% share in 2026. Manual collection methods remain widely used across healthcare settings due to their accessibility, established clinical protocols, and suitability for routine diagnostic procedures. Hospitals, clinics, and blood donation centers continue to rely on trained healthcare professionals to perform venipuncture efficiently, particularly in regions where healthcare infrastructure is already optimized around conventional collection practices. The familiarity and flexibility associated with manual procedures have helped maintain the segment’s dominant position.
Automated blood collection is emerging as the fastest-growing segment as healthcare providers increasingly prioritize operational efficiency, donor comfort, and sample quality. Automated systems enable greater precision in collecting targeted blood components while reducing variability associated with manual procedures. Rising demand for blood components in transfusion medicine, along with advancements in collection technologies that improve workflow and resource utilization, is accelerating adoption across specialized collection centers and modern healthcare facilities.
Application Segment Analysis: Diagnostics (Largest & Fastest-Growing Segment)
The diagnostics segment dominated the blood collection market with a 53.74% share in 2026 and also represented the fastest-growing application area. Blood samples are fundamental to diagnosing a broad range of medical conditions, supporting routine health assessments, disease detection, and treatment monitoring. The increasing prevalence of chronic and infectious diseases, combined with growing emphasis on preventive healthcare, has reinforced the importance of diagnostic testing worldwide. Continuous advancements in laboratory technologies and the expanding use of blood-based diagnostic procedures are further strengthening demand, enabling the segment to maintain both its leadership position and growth momentum.
End-use Segment Analysis: Hospitals and Clinics (Largest Segment) vs Diagnostic Centers (Fastest-Growing Segment)
Hospitals and clinics held the largest share of the blood collection market at 40.07% in 2026. These facilities manage a substantial volume of patient testing, emergency care, surgical procedures, and routine health evaluations, creating consistent demand for blood collection services. Their integrated healthcare infrastructure and ability to provide comprehensive diagnostic and treatment services make them the primary setting for blood sample collection across diverse patient populations.
Diagnostic centers are witnessing the fastest growth due to the increasing preference for specialized testing services and the expansion of outpatient diagnostics. These centers offer dedicated laboratory capabilities, efficient turnaround times, and access to a broad range of testing procedures. Growing awareness of preventive screening, rising demand for diagnostic accuracy, and the continued decentralization of healthcare services are contributing to the rapid expansion of diagnostic centers within the market.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Method | Manual Blood Collection, Automated Blood Collection | Manual Blood Collection | Automated Blood Collection |
| Application | Diagnostics, Treatment, Research | Diagnostics | Diagnostics |
| End-use | Hospitals and Clinics, Diagnostic Centers, Blood Banks, Academic and Research Institutes | Hospitals and Clinics | Diagnostic Centers |
| Product Type | Venous, Capillary | Venous | Capillary |
Competitive Landscape and Market Positioning
Leading companies in the blood collection market:
- Becton Dickinson and Company (United States)
- Abbott Laboratories (United States)
- F. Hoffmann-La Roche AG (Switzerland)
- Terumo Corporation (Japan)
- Thermo Fisher Scientific, Inc. (United States)
- Siemens Healthineers AG (Germany)
- Haemonetics Corporation (United States)
- Greiner AG (Austria)
- Nipro Corporation (Japan)
- Sarstedt AG & Co. KG (Germany)
Healthcare providers are placing greater emphasis on specimen quality, workflow efficiency, and patient safety, prompting manufacturers to expand beyond individual collection devices toward integrated sample management solutions. Competitive differentiation is increasingly shaped by innovations that reduce collection errors, improve user ergonomics, and support seamless compatibility with automated laboratory workflows. Suppliers are also strengthening their presence through clinical training, standardized product portfolios, and dependable supply capabilities, making operational consistency and procedural reliability key factors in purchasing decisions across healthcare settings.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Becton Dickinson and Company (United States) | |||||||
| Abbott Laboratories (United States) | |||||||
| F. Hoffmann-La Roche AG (Switzerland) | |||||||
| Terumo Corporation (Japan) | |||||||
| Thermo Fisher Scientific Inc. (United States) | |||||||
| Siemens Healthineers AG (Germany) | |||||||
| Haemonetics Corporation (United States) | |||||||
| Greiner AG (Austria) | |||||||
| Nipro Corporation (Japan) | |||||||
| Sarstedt AG & Co. KG (Germany) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Provacu | Jul-26 | Provacu commissioned a fully compliant ISO Class 7 and Class 8 cleanroom manufacturing facility in the UAE. The infrastructure investment significantly enhances regional production capabilities for in vitro diagnostic products and medical consumables, specifically targeting blood collection and diagnostic-related devices. |
| Vitestro | Mar-26 | Vitestro secured $70 million in a Series B funding round to scale its manufacturing infrastructure and accelerate the commercialization of its autonomous robotic blood collection technology. The capital injection supports global expansion strategies and U.S. market entry initiatives. |
| Neurogen Biomarking | Nov-25 | Neurogen Biomarking entered into a strategic partnership with Tasso to integrate needle-free capillary blood collection technology into its home-based Alzheimer's testing framework. The collaboration expands remote diagnostic capabilities by utilizing minimally invasive patient-led sampling methods. |
| Quest Diagnostics | Aug-25 | Quest Diagnostics completed the acquisition of Spectra Laboratories' clinical testing assets from Fresenius Medical Care. The transaction expands Quest's diagnostic testing capabilities and strengthens its core laboratory services portfolio within the clinical diagnostics ecosystem. |
| Tasso | Feb-25 | Tasso launched the Tile-T20 cartridge alongside the wearable Tasso Mini push-button lancet system. The introduction expands the company's proprietary product portfolio of at-home dried blood spot collection devices tailored specifically for decentralized clinical trials and remote molecular diagnostics. |
| BD | Dec-24 | BD and Babson Diagnostics expanded the commercial availability of their co-developed fingertip blood collection solution to urgent care clinics and physician practices. The strategic initiative scales geographic and operational distribution of minimally invasive diagnostic blood collection. |
| Kriya Medical Technologies | Sep-24 | Kriya Medical Technologies launched the ICHOR Medical Molding System, a highly automated production system designed for blood collection tube manufacturing. The infrastructure investment establishes a planned annual capacity of 250 million tubes, strengthening domestic production resilience for medical consumables. |
| Platinum Equity | Aug-24 | Platinum Equity finalized the acquisition of ASP Global, a specialized supplier of customized medical products. The strategic transaction expands the private equity firm's healthcare portfolio, integrating key clinical and laboratory medical consumables capabilities. |
| BD | Mar-24 | BD introduced the Vacutainer UltraTouch Push Button Blood Collection Set in India, incorporating advanced needle design technologies to optimize patient comfort. The product launch broadens the company's regional medical device portfolio and establishes an expanded competitive footprint in the Indian market. |
| HemoFlow | Jan-24 | HemoFlow launched its 500 Series blood scale and mixer devices in the United States alongside the complementary HemoVue cloud platform. The integrated technological solution enhances blood bank operational workflows by delivering real-time device connectivity and centralized data tracking. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Blood Collection Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Patient Type | Adult, Pediatric, Geriatric, Neonatal |
| Payer Type | Public Insurance, Private Insurance, Self-Pay, Uninsured |
| Procurement Model | Direct Procurement, Group Purchasing Organizations, Distributor-Mediated Procurement, Tender-Based Procurement |
Blood Collection Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Patient-Centric Collection Strategies |
|
| Phlebotomy Workflow Modernization |
|
| Home & Decentralized Blood Collection |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the blood collection market?
How much is the blood collection industry expected to grow by 2036?
What factors are increasing demand for blood collection solutions?
How is automation transforming the blood collection market?
Why does the manual blood collection segment lead the blood collection market?
Which end-use segment is growing the fastest in the blood collection market?
Why does North America lead the blood collection market?
What is driving blood collection market growth in Asia Pacific?
Which companies are driving growth in the blood collection landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization